Table 2 Top 10 TCR clonotypes information of representative sample from HD group (HD#3).
From: Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals
TRAV | TRA-CDR3 | TRAJ | TRAC | TRBV | TRB-CDR3 | TRBJ | TRBC | Ratio |
|---|---|---|---|---|---|---|---|---|
TRAV1-2 | CAVRDEDGQKLLF | TRAJ16 | TRAC | TRBV13 | CASSLWGANEQFF | TRBJ2-1 | TRBC2 | 4.56% |
TRAV9-2 | CAQRNTGGFKTIF | TRAJ9 | TRAC | TRBV7-2 | CASSSEQNQPQHF | TRBJ1-5 | TRBC1 | 3.64% |
TRAV5 | CAESITGKLVF | TRAJ47 | TRAC | TRBV20-1 | CSASSGGEQFF | TRBJ2-1 | TRBC2 | 2.83% |
TRAV5 | CAEISDGQKLLF | TRAJ16 | TRAC | TRBV20-1 | CSASQPGLVSREQFF | TRBJ2-1 | TRBC2 | 2.79% |
TRAV26-1 | CIVRSTGGGADGLTF | TRAJ45 | TRAC | TRBV20-1 | CSASGGLVLDTQYF | TRBJ2-3 | TRBC2 | 2.42% |
TRAV14/DV4 | CAMRDKQSNFGNEKLTF | TRAJ48 | TRAC | TRBV19 | CASMPRVAKNIQYF | TRBJ2-4 | TRBC2 | 2.31% |
TRAV13-2 | CAENFSNTGTASKLTF | TRAJ44 | TRAC | TRBV5-1 | CASSPARTGPYNEQFF | TRBJ2-1 | TRBC2 | 2.06% |
TRAV21 | CAVNDQGGKLIF | TRAJ23 | TRAC | TRBV10-3 | CAISEFGTVNEKLFF | TRBJ1-4 | TRBC1 | 1.73% |
TRAV14/DV4 | CAMREVNTGNQFYF | TRAJ49 | TRAC | TRBV19 | CASSGLAAPYNEQFF | TRBJ2-1 | TRBC2 | 1.10% |
TRAV8-6 | CAVLRLSF | TRAJ20 | TRAC | TRBV9 | CASSVEGGYYNEQFF | TRBJ2-1 | TRBC2 | 1.07% |
